Attacking Telomeres Offers First Effective Glioblastoma Therapy

News   Nov 14, 2017 | Original story from CNIO

 
Attacking Telomeres Offers First Effective Glioblastoma Therapy

Glioblastoma multiforme - MRI T1KM sagittal with contrast agent. Credit: Hellerhoff

 
 
 

RELATED ARTICLES

Using Epigenetic Signatures and Machine Learning to Improve Diagnosis

News

Unique epigenetic signatures for nine neurodevelopmental disorders have been identified, lending to a better method of diagnosis for disorders with much clinical overlap.

READ MORE

Valence Mapped: Brain study reveals roots of desire and dislike in the amygdala

News

Researchers map the amygdala's distinct but diverse and dynamic neighbourhoods where feelings are assigned.

READ MORE

Attacking 'Undruggable' Cancers from the Outside In

News

Many of the most common cancer-causing genes are so central to cellular function throughout the body that they are essentially 'undruggable'. Now, researchers have found a way to attack one of the most common drivers of lung, colorectal, and pancreatic cancer by targeting the proteins it produces on the outside of the cell.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE